Sign inJoin waitlistJoin the waitlist

Mark Heaney

Associate Professor of Medicine at CUMC, Died · New York Presbyterian Hospital

Credentials: · · ·

History

New York Presbyterian Hospital
Present

Hematology and Medical Oncology
1990–1993
Internal Medicine
1987–1990
University of Virginia School of Medicine
1983–1987

Research

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Blood · 2011 · 1,083 citations
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
Journal of Clinical Oncology · 2005 · 769 citations
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
Blood · 2014 · 440 citations

DS
David Scheinberg
10 papers
John Mascarenhas
9 papers
Ruben Mesa
9 papers
Ronald Hoffman
8 papers
Joseph Jurcic
7 papers
Ross Levine
7 papers
AZ
Andrew Zelenetz
6 papers
Jason Gotlib
6 papers
OO
Owen O’Connor
6 papers
RR
Raajit Rampal
6 papers · 2 as a fellow
AK
Andrew Kuykendall
5 papers
Angela Fleischman
5 papers

Clinical trials

Three Dosing Schedules of Oral Rigosertib in MDS Patients
Principal investigator · Withdrawn · Phase 1
Traws Pharma, Inc.
2014–2019
Revlimid in Transfusion Dependent Patients
Principal investigator · Completed · Phase 2
Columbia University
2009–2022
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
Study chair · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
1999–2000
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Site PI · Recruiting · Phase 1
Cellenkos, Inc.
2022–2026